Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9115)
All Articles published online
|
Publishing Process of This Article
|
Mar 28, 2014 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lee SC, Tan HT, Chung MCM. Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: Current status and future prospects. World J Gastroenterol 2014; 20(12): 3112-3124 [PMID: 24696598 DOI: 10.3748/wjg.v20.i12.3112] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i12/3112.htm |
| Number | Citing Articles |
| 1 |
Hanaa Hibishy Gaballah, Soha Said Zakaria, Saber Abdelrahman Ismail. Activity and Expression Pattern of NF-κB/P65 in Peripheral Blood from Hepatocellular Carcinoma Patients - Link to Hypoxia Inducible Factor -1α. Asian Pacific Journal of Cancer Prevention 2014; 15(16): 6911 doi: 10.7314/APJCP.2014.15.16.6911
|
| 2 |
Fan-Di Meng, Ji-Chao Wei, Kai Qu, Zhi-Xin Wang, Qi-Fei Wu, Ming-Hui Tai, Hao-Chen Liu, Rui-Yao Zhang, Chang Liu. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(1): 196-213 doi: 10.3748/wjg.v21.i1.196
|
| 3 |
Wei Lan, Zhentao Tang, Haibo Liao, Qingfeng Chen, Yi-Ping Phoebe Chen, Zhaolei Zhang, Jianxin Wang. MULGONET: An interpretable neural network framework to integrate multi-omics data for cancer recurrence prediction and biomarker discovery. Fundamental Research 2025; doi: 10.1016/j.fmre.2025.01.004
|
| 4 |
Chiao-Fang Teng, Tsai-Chung Li, Hsi-Yuan Huang, Jia-Hui Lin, Wen-Shu Chen, Woei-Cherng Shyu, Han-Chieh Wu, Cheng-Yuan Peng, Ih-Jen Su, Long-Bin Jeng. Next-Generation Sequencing-Based Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma Predicts Hepatocellular Carcinoma Recurrence. Viruses 2020; 12(8): 796 doi: 10.3390/v12080796
|
| 5 |
Ye Jin, Zhi-Yong Liang, Wei-Xun Zhou, Li Zhou. Expression, clinicopathologic and prognostic significance of plasminogen activator inhibitor 1 in hepatocellular carcinoma. Cancer Biomarkers 2020; 27(3): 285 doi: 10.3233/CBM-190560
|
| 6 |
Daniel Shouval, Scott L. Friedman. Focusing on the past, present, and future of hepatology. Journal of Hepatology 2014; 61(6): 1196 doi: 10.1016/j.jhep.2014.08.039
|
| 7 |
Matthias Ocker. Biomarkers for hepatocellular carcinoma: What’s new on the horizon?. World Journal of Gastroenterology 2018; 24(35): 3974-3979 doi: 10.3748/wjg.v24.i35.3974
|
| 8 |
Xiaonian Zhu, Meng Yan, Wei Luo, Wei Liu, Yuan Ren, Chunhua Bei, Guifang Tang, Ruiling Chen, Shengkui Tan. Expression and clinical significance of PcG-associated protein RYBP in hepatocellular carcinoma. Oncology Letters 2017; 13(1): 141 doi: 10.3892/ol.2016.5380
|
| 9 |
Olivier Fernandez, Maria Urrutia, Stéphane Bernillon, Catherine Giauffret, François Tardieu, Jacques Le Gouis, Nicolas Langlade, Alain Charcosset, Annick Moing, Yves Gibon. Fortune telling: metabolic markers of plant performance. Metabolomics 2016; 12(10) doi: 10.1007/s11306-016-1099-1
|
| 10 |
Chiao-Fang Teng, Han-Chieh Wu, Ih-Jen Su, Long-Bin Jeng. Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma. Viruses 2020; 12(9): 945 doi: 10.3390/v12090945
|
| 11 |
Huan-Hsien Kuo, Ruey-Jen Lin, Jung-Tung Hung, Chung-Bao Hsieh, Tsai-Hsien Hung, Fei-Yun Lo, Ming-Yi Ho, Chau-Ting Yeh, Yen-Lin Huang, John Yu, Alice L. Yu. High expression FUT1 and B3GALT5 is an independent predictor of postoperative recurrence and survival in hepatocellular carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-11136-w
|
| 12 |
Xiuchao Wang, He Ren, Tiansuo Zhao, Jing Chen, Wei Sun, Yan Sun, Weidong Ma, Jian Wang, Chuntao Gao, Song Gao, Mingxiao Lang, Li Jia, Jihui Hao. Stem cell factor is a novel independent prognostic biomarker for hepatocellular carcinoma after curative resection. Carcinogenesis 2014; 35(10): 2283 doi: 10.1093/carcin/bgu162
|
| 13 |
Yuting Gao, Yi Gong, Yiwei Liu, Yu Xue, Kangning Zheng, Yinglin Guo, Liyuan Hao, Qing Peng, Xinli Shi. Integrated analysis of transcriptomics and metabolomics in human hepatocellular carcinoma HepG2215 cells after YAP1 knockdown. Acta Histochemica 2023; 125(1): 151987 doi: 10.1016/j.acthis.2022.151987
|
| 14 |
Shu Shen, Junjie Kong, Yiwen Qiu, Xianwei Yang, Wentao Wang, Lvnan Yan. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis. Journal of Cellular Biochemistry 2019; 120(6): 10069 doi: 10.1002/jcb.28290
|
| 15 |
Qian Liu, Chunfu Zhu, Yanfen Dong. LncRNA TCTN2 Promotes the Malignant Development of Hepatocellular
Carcinoma via Regulating mIR-1285-3p/ARF6 Axis. Recent Patents on Anti-Cancer Drug Discovery 2023; 18(4): 517 doi: 10.2174/1574892818666221019163656
|
| 16 |
Ye Jin, Zhi-Yong Liang, Wei-Xun Zhou, Li Zhou. High MMP14 expression is predictive of poor prognosis in resectable hepatocellular carcinoma. Pathology 2020; 52(3): 359 doi: 10.1016/j.pathol.2020.01.436
|
| 17 |
G.J. Wengert, H. Bickel, J. Breitenseher, A. Ba-Ssalamah. Primäre Lebertumoren. Der Radiologe 2015; 55(1): 27 doi: 10.1007/s00117-014-2705-8
|
| 18 |
Youfu Zhang, Xuyang Wang, Huaxiang Wang, Yi Jiang, Zhidan Xu, Laibang Luo. Elevated Small Nuclear Ribonucleoprotein Polypeptide an Expression Correlated With Poor Prognosis and Immune Infiltrates in Patients With Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.893107
|
| 19 |
Chenghua Cui, Zheming Lu, Liu Yang, Yanhong Gao, Wei Liu, Liankun Gu, Chen Yang, James Wilson, Zhiqian Zhang, Baocai Xing, Dajun Deng, Zhong Sheng Sun. Genome‐wide identification of differential methylation between primary and recurrent hepatocellular carcinomas. Molecular Carcinogenesis 2016; 55(7): 1163 doi: 10.1002/mc.22359
|
| 20 |
H.Z. Dundar, F. Aksoy, S. Ak Aksoy, P. Tasar, N. Ugras, B. Tunca, U. Egeli, G. Cecener, O. Yerci, E. Kaya. Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus–Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation. Transplantation Proceedings 2019; 51(4): 1157 doi: 10.1016/j.transproceed.2019.01.089
|
| 21 |
Junjie Kong, Tao Wang, Shu Shen, Zifei Zhang, Xianwei Yang, Wentao Wang. A genomic-clinical nomogram predicting recurrence-free survival for patients diagnosed with hepatocellular carcinoma. PeerJ 2019; 7: e7942 doi: 10.7717/peerj.7942
|
| 22 |
Yongxin Zhang, Xiaofei Lv, Jiliang Qiu, Bin Zhang, Lu Zhang, Jin Fang, Minmin Li, Luyan Chen, Fei Wang, Shuyi Liu, Shuixing Zhang. Deep Learning With 3D Convolutional Neural Network for Noninvasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma. Journal of Magnetic Resonance Imaging 2021; 54(1): 134 doi: 10.1002/jmri.27538
|
| 23 |
Franziska Mußbach, Petra Henklein, Martin Westermann, Utz Settmacher, Frank-D. Böhmer, Roland Kaufmann. Proteinase-activated receptor 1- and 4-promoted migration of Hep3B hepatocellular carcinoma cells depends on ROS formation and RTK transactivation. Journal of Cancer Research and Clinical Oncology 2015; 141(5): 813 doi: 10.1007/s00432-014-1863-4
|
| 24 |
Ching-Feng Weng, Max K. Leong. . Advances in Molecular Toxicology 2019; 13: 31 doi: 10.1016/B978-0-444-64293-6.00002-6
|
| 25 |
Jiang Chen, Jie Zhao, Rui Ma, Hui Lin, Xiao Liang, Xiujun Cai, Kwan Man. Prognostic Significance of E-Cadherin Expression in Hepatocellular Carcinoma: A Meta-Analysis. PLoS ONE 2014; 9(8): e103952 doi: 10.1371/journal.pone.0103952
|
| 26 |
Bo Li, Aixia Liu, Yi Wen, Guang Yang, Jing Zhao, Xiaohan Li, Yuanli Mao, Boan Li. The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real‐world data. Journal of Clinical Laboratory Analysis 2021; 35(9) doi: 10.1002/jcla.23932
|
| 27 |
Andrew Gabrielson, Yunan Wu, Hongkun Wang, Jiji Jiang, Bhaskar Kallakury, Zoran Gatalica, Sandeep Reddy, David Kleiner, Thomas Fishbein, Lynt Johnson, Eddie Island, Rohit Satoskar, Filip Banovac, Reena Jha, Jaydeep Kachhela, Perry Feng, Tiger Zhang, Anteneh Tesfaye, Petra Prins, Christopher Loffredo, John Marshall, Louis Weiner, Michael Atkins, Aiwu Ruth He. Intratumoral CD3 and CD8 T-cell Densities Associated with Relapse-Free Survival in HCC. Cancer Immunology Research 2016; 4(5): 419 doi: 10.1158/2326-6066.CIR-15-0110
|
| 28 |
Feng Wang, Hou-Qun Ying, Bang-Shun He, Yu-Qin Pan, Qi-Wen Deng, Hui-Ling Sun, Jie Chen, Xian Liu, Shu-Kui Wang. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget 2015; 6(10): 7899 doi: 10.18632/oncotarget.3219
|
| 29 |
Guido Torzilli, Matteo Donadon, Jacques Belghiti, Norihiro Kokudo, Tadatoshi Takayama, Alessandro Ferrero, Gennaro Nuzzo, Jean-Nicolas Vauthey, Michael A. Choti, Eduardo De Santibanes, Masatoshi Makuuchi. Predicting Individual Survival After Hepatectomy for Hepatocellular Carcinoma: a Novel Nomogram from the “HCC East & West Study Group”. Journal of Gastrointestinal Surgery 2016; 20(6): 1154 doi: 10.1007/s11605-016-3132-0
|
| 30 |
Chao Guo, Shuhuang Zhou, Weimin Yi, Pingzhou Yang, Ou Li, Jianming Liu, Chuang Peng. Long non-coding RNA muskelin 1 antisense RNA (MKLN1-AS) is a potential diagnostic and prognostic biomarker and therapeutic target for hepatocellular carcinoma. Experimental and Molecular Pathology 2021; 120: 104638 doi: 10.1016/j.yexmp.2021.104638
|
| 31 |
Ye Jin, Zhi-Yong Liang, Wei-Xun Zhou, Li Zhou. An MMP-based risk score strongly distinguishes prognosis in hepatocellular carcinoma after resection. Future Oncology 2022; 18(26): 2903 doi: 10.2217/fon-2021-1558
|
| 32 |
Jinxia Liu, Guijuan Zong, Chengliang Zhang, Chunsun Li, Xudong Chen, Yixin Zhang. Anxiety and serum catecholamines as predictors of survival and recurrence in hepatocellular carcinoma. Psycho-Oncology 2017; 26(9): 1347 doi: 10.1002/pon.4305
|
| 33 |
Zhongyi Guo, Hui Shi, Chunlei Li, Yuanyuan Luo, Sixue Bi, Rongmin Yu, Haoran Wang, Wanying Liu, Jianhua Zhu, Weijuan Huang, Liyan Song. Identification and Characterization of a Novel Protein ASP-3 Purified from Arca subcrenata and Its Antitumor Mechanism. Marine Drugs 2019; 17(9): 528 doi: 10.3390/md17090528
|
| 34 |
Xiao-Pin Ma, Guopeng Yu, Xubo Chen, Qianyi Xiao, Zhuqing Shi, Lu-Yao Zhang, Haitao Chen, Pengyin Zhang, Dong-Lin Ding, Hui-Xing Huang, Hexige Saiyin, Tao-Yang Chen, Pei-Xin Lu, Neng-Jin Wang, Hongjie Yu, Carly Conran, Jielin Sun, S. Lilly Zheng, Jianfeng Xu, Long Yu, De-Ke Jiang. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma. Tumor Biology 2016; 37(7): 9931 doi: 10.1007/s13277-016-4897-1
|
| 35 |
Limin Ma, Changming Tao, Yingying Zhang, Enas Abdulhay. MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT Pathway. Journal of Healthcare Engineering 2022; 2022: 1 doi: 10.1155/2022/7026174
|
| 36 |
Ai‐Hua Tong, Juan Tan, Jin‐Hua Zhang, Fang‐Jiang Xu, Fu‐Yuan Li, Chun‐Yu Cao. Overexpression of RYBP inhibits proliferation, invasion, and chemoresistance to cisplatin in anaplastic thyroid cancer cells via the EGFR pathway. Journal of Biochemical and Molecular Toxicology 2019; 33(2) doi: 10.1002/jbt.22241
|
| 37 |
Jie Cai, Xuehua Sun, Han Guo, Xiaoye Qu, Hongting Huang, Chang Yu, Hailong Wu, Yueqiu Gao, Xiaoni Kong, Qiang Xia. Non-metabolic role of UCK2 links EGFR-AKT pathway activation to metastasis enhancement in hepatocellular carcinoma. Oncogenesis 2020; 9(12) doi: 10.1038/s41389-020-00287-7
|
| 38 |
Bin Qiu, Meng-Fei Zhao, Zhen-Dong Yue, Hong-Wei Zhao, Lei Wang, Zhen-Hua Fan, Fu-Liang He, Shan Dai, Jian-Nan Yao, Fu-Quan Liu. Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension. World Journal of Gastroenterology 2015; 21(43): 12439-12447 doi: 10.3748/wjg.v21.i43.12439
|
| 39 |
Xiuli Mu, Xi Wang, Yan Wei, Chaochao Wen, Qi Zhang, Chunyang Xu, Chang Liu, Chan Zhang, Fanxiu Meng, Na Zhao, Tao Gong, Rui Guo, Gongqin Sun, Gaopeng Li, Hongwei Zhang, Qin Qin, Jun Xu, Xiushan Dong, Lumei Wang, Baofeng Yu. ApoE-modified liposomes mediate the antitumour effect of survivin promoter-driven HSVtk in hepatocellular carcinoma. Cancer Gene Therapy 2020; 27(10-11): 754 doi: 10.1038/s41417-019-0145-3
|
| 40 |
Chun-Peng Yu, Shui Yu, Lei Shi, Song Wang, Zi-Xiang Li, Yan-Hua Wang, Cheng-Jian Sun, Jun Liang. FoxM1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma by targeting Snai1. Molecular Medicine Reports 2017; 16(4): 5181 doi: 10.3892/mmr.2017.7223
|
| 41 |
Heng-Yuan Hsu, Ming-Chin Yu, Chao-Wei Lee, Hsin-I Tsai, Chang-Mu Sung, Chun-Wei Chen, Shu-Wei Huang, Cheng-Yu Lin, Wen-Juei Jeng, Wei-Chen Lee, Miin-Fu Chen. RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3748-9
|
| 42 |
Xiaonian Zhu, Guangzi Qi, Cong Li, Chunhua Bei, Chao Tan, Ying Zhang, Wenxiang Shi, Wen Zeng, Juan Kong, Yuanyuan Fu, Shengkui Tan. Expression and Clinical Significance of CMTM6 in Hepatocellular Carcinoma. DNA and Cell Biology 2019; 38(2): 193 doi: 10.1089/dna.2018.4513
|
| 43 |
Wei Song, Jingjing Zhang, Jianbo Zhang, Miaomiao Sun, Qingxin Xia. Overexpression of lncRNA PIK3CD-AS1 promotes expression of LATS1 by competitive binding with microRNA-566 to inhibit the growth, invasion and metastasis of hepatocellular carcinoma cells. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0857-3
|
| 44 |
Haixia Lin, Laura E. Ewing, Igor Koturbash, Bill J. Gurley, Isabelle R. Miousse. MicroRNAs as biomarkers for liver injury: Current knowledge, challenges and future prospects. Food and Chemical Toxicology 2017; 110: 229 doi: 10.1016/j.fct.2017.10.026
|
| 45 |
Jianfei Tu, Zhongwei Zhao, Min Xu, Minjiang Chen, Qiaoyou Weng, Jiangmei Wang, Jiansong Ji. Retracted: LINC00707 contributes to hepatocellular carcinoma progression via sponging miR‐206 to increase CDK14. Journal of Cellular Physiology 2019; 234(7): 10615 doi: 10.1002/jcp.27737
|
| 46 |
Bo Liang, Chunhong Jia, Yu Huang, Hua He, Jialu Li, Hui Liao, Xiao Liu, Xincheng Liu, Xiaochun Bai, Dinghua Yang. TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT. Digestive Diseases and Sciences 2015; 60(8): 2360 doi: 10.1007/s10620-015-3730-9
|
| 47 |
Wujun Li, Shaobo Zhang. CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2017; 25(2): 285 doi: 10.3727/096504016X14732523471442
|
| 48 |
Shengyan Xi, Ying Peng, Gerald Y. Minuk, Mengmeng Shi, Biqian Fu, Jiaqi Yang, Qian Li, Yuewen Gong, Lifeng Yue, Lili Li, Jinhua Guo, Yang Peng, Yanhui Wang. The combination effects of Shen-Ling-Bai-Zhu on promoting apoptosis of transplanted H22 hepatocellular carcinoma in mice receiving chemotherapy. Journal of Ethnopharmacology 2016; 190: 1 doi: 10.1016/j.jep.2016.05.055
|
| 49 |
Wei Yuan, Maowei Yang, Yue Zhu. Development and validation of a gene signature predicting the risk of postmenopausal osteoporosis. Bone & Joint Research 2022; 11(8): 548 doi: 10.1302/2046-3758.118.BJR-2021-0565.R1
|
| 50 |
Huixin Zhang, Muoyan Xu, Jiashen Shao, Huifang Kong, Xudong Gao, Wei Zhang, Xiujuan Chang, Bin Yang, Yan Chen, Zheng Dong, Jiagan Huang, Zhen Zeng, Yongping Yang. Age independent survival benefit for patients with small hepatocellular carcinoma undergoing percutaneous cryoablation: A propensity scores matching study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1072054
|
| 51 |
Lanjing Zhang. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; : 95 doi: 10.1007/978-3-319-68082-8_6
|
| 52 |
Jifei Wang, Dasheng Wu, Meili Sun, Zhenpeng Peng, Yingyu Lin, Hongxin Lin, Jiazhao Chen, Tingyu Long, Zi-Ping Li, Chuanmiao Xie, Bingsheng Huang, Shi-Ting Feng. Deep Segmentation Feature-Based Radiomics Improves Recurrence Prediction of Hepatocellular Carcinoma. BME Frontiers 2022; 2022 doi: 10.34133/2022/9793716
|
| 53 |
Yong-Rong Liang, Zhe Guo, Jing-Hang Jiang, Bang-De Xiang, Le-Qun Li. Thymosin α1 therapy subsequent to radical hepatectomy in patients with hepatitis B virus-associated hepatocellular carcinoma: A retrospective controlled study. Oncology Letters 2016; 12(5): 3513 doi: 10.3892/ol.2016.5121
|
| 54 |
Cunhua Shao, Gongpan Liu, Xiaobin Zhang, Anyun Li, Xingjun Guo. <p>Long Noncoding RNA RMRP Suppresses the Tumorigenesis of Hepatocellular Carcinoma Through Targeting microRNA-766</p>. OncoTargets and Therapy 2020; : 3013 doi: 10.2147/OTT.S243736
|
| 55 |
Ye Jin, Zhi-Yong Liang, Wei-Xun Zhou, Li Zhou. Plasminogen activator inhibitor 2 (PAI2) inhibits invasive potential of hepatocellular carcinoma cells in vitro via uPA- and RB/E2F1-related mechanisms. Hepatology International 2019; 13(2): 180 doi: 10.1007/s12072-018-9920-8
|
| 56 |
Lei Zhang, Martin H. Bluth, Amarpreet Bhalla. Molecular Diagnostics in the Neoplasms of the Pancreas, Liver, Gallbladder, and Extrahepatic Biliary Tract. Clinics in Laboratory Medicine 2018; 38(2): 367 doi: 10.1016/j.cll.2018.03.003
|
| 57 |
Xi Ma, Lin Zhou, Shusen Zheng. Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinoma. PeerJ 2020; 8: e8930 doi: 10.7717/peerj.8930
|
| 58 |
Weibang Yang, Jinxing Wei, Lihong Lv, Jiyan Xie, Ang Li, Zhihua Zheng, Wenfeng Zhuo, Peiqing Liu, Jun Min. p62 Promotes Malignancy of Hepatocellular Carcinoma by Regulating the Secretion of Exosomes and the Localization of β-Catenin. Frontiers in Bioscience-Landmark 2022; 27(3) doi: 10.31083/j.fbl2703089
|
| 59 |
Guifang Yu, Jieheng Lin, Chengcheng Liu, Kailian Hou, Min Liang, Boyun Shi. Long non-coding RNA SPRY4-IT1 promotes development of hepatic cellular carcinoma by interacting with ERRα and predicts poor prognosis. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-16781-9
|
| 60 |
Hirotaka Kato, Shinya Hayami, Masaki Ueno, Norihiko Suzaki, Masashi Nakamura, Tomohiro Yoshimura, Atsushi Miyamoto, Yoshinobu Shigekawa, Ken‐Ichi Okada, Motoki Miyazawa, Yuji Kitahata, Shogo Ehata, Ryuji Hamamoto, Hiroki Yamaue, Manabu Kawai. Histone methyltransferase SUV420H1/KMT5B contributes to poor prognosis in hepatocellular carcinoma. Cancer Science 2024; 115(2): 385 doi: 10.1111/cas.16038
|
| 61 |
Haoyang Mi, Ravi Varadhan, Ashley M. Cimino-Mathews, Leisha A. Emens, Cesar A. Santa-Maria, Aleksander S. Popel. Spatial Architecture of Single-Cell and Vasculature in Tumor Microenvironment Predicts Clinical Outcomes in Triple-Negative Breast Cancer. Modern Pathology 2025; 38(2): 100652 doi: 10.1016/j.modpat.2024.100652
|
| 62 |
Krizia Pocino, Cecilia Napodano, Mariapaola Marino, Riccardo Di Santo, Luca Miele, Nicoletta De Matthaeis, Francesca Gulli, Raffaele Saporito, Gian Ludovico Rapaccini, Gabriele Ciasca, Umberto Basile. A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma. Cancers 2021; 14(1): 11 doi: 10.3390/cancers14010011
|
| 63 |
Aline M. A. Martins, J. Huygens P. Garcia, Marcos N. Eberlin. Mass Spectrometry as a Clinical Integrative Tool to Evaluate Hepatocellular Carcinoma: Moving to the Mainstream. Expert Review of Gastroenterology & Hepatology 2019; 13(9): 821 doi: 10.1080/17474124.2019.1651643
|
| 64 |
Brian I. Shaw, Aaron Lucander, Kadiyala V. Ravindra. Very Late Recurrence of Hepatocellular Carcinoma After Orthotopic Liver Transplantation: Presentation and Management. Transplantation Direct 2019; 5(9): e483 doi: 10.1097/TXD.0000000000000921
|
| 65 |
Xin Song, Shidong Zhang, Run Tian, Chuanjun Zheng, Yuge Xu, Tianxian Wang, Chunhua Bei, Huixia Zhang, Xiao He, Xiaonian Zhu, Shengkui Tan. Expression and clinical significance of CMTM1 in hepatocellular carcinoma. Open Medicine 2021; 16(1): 217 doi: 10.1515/med-2021-0221
|
| 66 |
Binkui Li, Pinzhu Huang, Jiliang Qiu, Yadi Liao, Jian Hong, Yunfei Yuan. MicroRNA-130a is down-regulated in hepatocellular carcinoma and associates with poor prognosis. Medical Oncology 2014; 31(10) doi: 10.1007/s12032-014-0230-2
|